Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32-1 - SOLAREDGE TECHNOLOGIES, INC. | exhibit_32-1.htm |
| EX-32.2 - EXHIBIT 32.2 - SOLAREDGE TECHNOLOGIES, INC. | exhibit_32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - SOLAREDGE TECHNOLOGIES, INC. | exhibit_31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - SOLAREDGE TECHNOLOGIES, INC. | exhibit_31-1.htm |
| EX-10.1 - EXHIBIT 10.1 - SOLAREDGE TECHNOLOGIES, INC. | exhibit_10-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended March 31, 2017
OR
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from to
Commission File No. 001-36894
SOLAREDGE TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
20-5338862
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(IRS Employer
Identification No.) |
|
|
1 HaMada Street
Herziliya Pituach 4673335, Israel (Address of principal executive offices, zip code) |
||
|
972 (9) 957-6620
|
||
|
(Registrant's telephone number, including area code)
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer
|
☒
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☐ (Do not check if a smaller reporting company)
|
Smaller Reporting Company
|
☐
|
|
Emerging growth company
|
☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☒
As of May 1, 2017, there were 41,554,048 shares of the registrant's common stock, par value of $0.0001 per share, outstanding.
SOLAREDGE TECHNOLOGIES, INC.
FORM 10-Q
FOR THE QUARTER ENDED March 31, 2017
INDEX
FORM 10-Q
FOR THE QUARTER ENDED March 31, 2017
INDEX
|
3
|
||
|
3
|
||
|
Condensed Consolidated Balance Sheets as of March 31, 2017 (unaudited)
|
||
|
Condensed Consolidated Statements of Operations for the three months ended March 31, 2017 and, 2016 (unaudited)
|
||
|
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2017 and 2016 (unaudited)
|
||
|
Notes to the Condensed Consolidated Financial Statements
|
||
|
4
|
||
|
11
|
||
|
11
|
||
|
12
|
||
|
12
|
||
|
12
|
||
|
12
|
||
|
13
|
||
|
13
|
||
|
13
|
||
|
14
|
||
|
14
|
||
2
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
INTERIM CONSOLIDATED FINANCIAL STATEMENTS
AS OF MARCH 31, 2017
IN U.S. DOLLARS
UNAUDITED
INDEX
|
Page
|
|
|
F-2 - F-3
|
|
|
F-4
|
|
|
F-5
|
|
|
F-6 - F-7
|
|
|
F-8 - F-23
|
3
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
U.S. dollars in thousands (except share and per share data)
|
March 31,
|
December 31,
|
|||||||
|
2017
|
2016
|
|||||||
|
Unaudited
|
||||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
119,933
|
$
|
104,683
|
||||
|
Restricted cash
|
991
|
897
|
||||||
|
Marketable Securities
|
81,800
|
74,465
|
||||||
|
Trade receivables, net
|
79,268
|
71,041
|
||||||
|
Prepaid expenses and other accounts receivable
|
26,561
|
21,347
|
||||||
|
Inventories
|
60,913
|
67,363
|
||||||
|
Total current assets
|
369,466
|
339,796
|
||||||
|
LONG-TERM ASSETS:
|
||||||||
|
Marketable securities
|
44,893
|
44,262
|
||||||
|
Property, equipment and intangible assets, net
|
37,933
|
37,381
|
||||||
|
Prepaid expenses and lease deposits
|
594
|
489
|
||||||
|
Deferred tax assets, net
|
4,084
|
2,815
|
||||||
|
Total long term assets
|
87,504
|
84,947
|
||||||
|
Total assets
|
$
|
456,970
|
$
|
424,743
|
||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 2
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
U.S. dollars in thousands (except share and per share data)
|
March 31,
|
December 31,
|
|||||||
|
2017
|
2016
|
|||||||
|
Unaudited
|
||||||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables, net
|
$
|
43,740
|
$
|
34,001
|
||||
|
Employees and payroll accruals
|
11,767
|
13,018
|
||||||
|
Warranty obligations
|
12,895
|
13,616
|
||||||
|
Deferred revenues
|
1,025
|
1,202
|
||||||
|
Accrued expenses and other accounts payable
|
9,189
|
8,648
|
||||||
|
Total current liabilities
|
78,616
|
70,485
|
||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Warranty obligations
|
48,230
|
44,759
|
||||||
|
Deferred revenues
|
20,902
|
18,660
|
||||||
|
Lease incentive obligation
|
1,987
|
2,061
|
||||||
|
Total long-term liabilities
|
71,119
|
65,480
|
||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
|
STOCKHOLDERS’ EQUITY:
|
||||||||
|
Common stock of $0.0001 par value - Authorized: 125,000,000 shares as of March 31, 2017 (unaudited) and December 31, 2016; issued and outstanding: 41,532,545 and 41,259,391 shares as of March 31, 2017 (unaudited) and December 31, 2016, respectively
|
4
|
4
|
||||||
|
Additional paid-in capital
|
311,081
|
307,098
|
||||||
|
Accumulated other comprehensive loss
|
(25
|
)
|
(324
|
)
|
||||
|
Accumulated deficit
|
(3,825
|
)
|
(18,000
|
)
|
||||
|
Total stockholders’ equity
|
307,235
|
288,778
|
||||||
|
Total liabilities and stockholders’ equity
|
$
|
456,970
|
$
|
424,743
|
||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 3
AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
U.S. dollars in thousands (except share and per share data)
|
Three months ended
March 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
Unaudited
|
||||||||
|
Revenues
|
$
|
115,054
|
$
|
125,205
|
||||
|
Cost of revenues
|
76,378
|
84,471
|
||||||
|
Gross profit
|
38,676
|
40,734
|
||||||
|
Operating expenses:
|
||||||||
|
Research and development, net
|
11,458
|
8,709
|
||||||
|
Sales and marketing
|
10,775
|
8,826
|
||||||
|
General and administrative
|
4,439
|
3,460
|
||||||
|
Total operating expenses
|
26,672
|
20,995
|
||||||
|
Operating income
|
12,004
|
19,739
|
||||||
|
Financial income, net
|
1,410
|
2,029
|
||||||
|
Income before taxes on income
|
13,414
|
21,768
|
||||||
|
Tax benefit (taxes on income)
|
761
|
(969
|
)
|
|||||
|
Net income
|
$
|
14,175
|
$
|
20,799
|
||||
|
Net basic earnings per share of common stock
|
$
|
0.34
|
$
|
0.52
|
||||
|
Net diluted earnings per share of common stock
|
$
|
0.32
|
$
|
0.47
|
||||
|
Weighted average number of shares used in computing net basic earnings per share of common stock
|
41,348,225
|
40,362,093
|
||||||
|
Weighted average number of shares used in computing net diluted earnings per share of common stock
|
43,837,505
|
44,577,901
|
||||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
U.S. dollars in thousands (except share and per share data)
|
Three months ended
March 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
Unaudited
|
||||||||
|
Net income
|
$
|
14,175
|
$
|
20,799
|
||||
|
Other comprehensive income (loss):
|
||||||||
|
Available-for-sale securities:
|
||||||||
|
Changes in unrealized gains, net of tax benefit
|
28
|
87
|
||||||
|
Reclassification adjustments for losses included in net income
|
-
|
1
|
||||||
|
Net change
|
28
|
88
|
||||||
|
Cash flow hedges:
|
||||||||
|
Changes in unrealized gains, net of tax expense
|
909
|
668
|
||||||
|
Reclassification adjustments for gains and losses , net of tax expense included in net income
|
(395
|
)
|
(33
|
)
|
||||
|
Net change
|
514
|
635
|
||||||
|
Foreign currency translation adjustments, net
|
(243
|
)
|
(13
|
)
|
||||
|
Total other comprehensive income
|
299
|
710
|
||||||
|
Comprehensive income
|
$
|
14,474
|
$
|
21,509
|
||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
U.S. dollars in thousands
|
Three months ended
March 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
Unaudited
|
||||||||
|
Cash flows provided by operating activities:
|
||||||||
|
Net income
|
$
|
14,175
|
$
|
20,799
|
||||
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation and amortization of property, equipment and intangible assets
|
1,520
|
993
|
||||||
|
Amortization of premiums on available-for-sale marketable securities
|
383
|
174
|
||||||
|
Stock-based compensation
|
3,612
|
2,632
|
||||||
|
Deferred tax assets, net
|
(1,333
|
)
|
(100
|
)
|
||||
|
Realized losses on Cash Flow Hedges
|
-
|
2
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Inventories
|
6,453
|
2,006
|
||||||
|
Prepaid expenses and other accounts receivable
|
(4,583
|
)
|
6,682
|
|||||
|
Trade receivables, net
|
(8,070
|
)
|
(9,413
|
)
|
||||
|
Trade payables
|
9,734
|
(16,853
|
)
|
|||||
|
Employees and payroll accruals
|
(1,272
|
)
|
(556
|
)
|
||||
|
Warranty obligations
|
2,750
|
5,765
|
||||||
|
Deferred revenues
|
2,060
|
2,496
|
||||||
|
Accrued expenses and other accounts payable
|
311
|
770
|
||||||
|
Lease incentive obligation
|
(74
|
)
|
(55
|
)
|
||||
|
Net cash provided by operating activities
|
25,666
|
15,342
|
||||||
|
Cash flows used in investing activities:
|
||||||||
|
Purchase of property and equipment
|
(1,872
|
)
|
(5,909
|
)
|
||||
|
Decrease (increase) in restricted cash
|
(94
|
)
|
2,473
|
|||||
|
Increase in short and long-term lease deposits
|
(66
|
)
|
(14
|
)
|
||||
|
Investment in available-for-sale marketable securities
|
(24,070
|
)
|
(36,023
|
)
|
||||
|
Maturities of available-for-sale marketable securities
|
15,665
|
1,000
|
||||||
|
Net cash used in investing activities
|
(10,437
|
)
|
(38,473
|
)
|
||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 6
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Cont.)
U.S. dollars in thousands
|
Three months ended
March 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
Unaudited
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from issuance of shares upon exercise of options
|
371
|
1,167
|
||||||
|
Net cash provided by financing activities
|
371
|
1,167
|
||||||
|
Increase (decrease) in cash and cash equivalents
|
15,600
|
(21,964
|
)
|
|||||
|
Cash and cash equivalents at the beginning of the period
|
104,683
|
106,150
|
||||||
|
Effect of exchange rate differences on cash and cash equivalents
|
(350
|
)
|
(116
|
)
|
||||
|
Cash and cash equivalents at the end of the period
|
119,933
|
84,070
|
||||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 7
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 1:- |
GENERAL
|
| a. |
SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughput from each and every module through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC) and (iii) a related cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters of a solar PV system to enable customers and system owners as applicable, to monitor and manage the solar PV systems. In addition, the Company has a storage solution that is used to increase energy independence and maximize self-consumption for homeowners by utilizing a battery that is sold separately by third party manufacturers, to store and supply power as needed (the “StorEdge solution”). The StorEdge solution is designed to provide smart energy functions such as maximizing self-consumption, Time-of-Use programming for desired hours of the day, and home energy backup solutions.
|
The Company and its subsidiaries sells its products worldwide directly to large solar installers and engineering, procurement and construction firms (“EPCs”), as well as through large distributors and electrical equipment wholesalers to smaller solar installers.
| b. |
Recent accounting pronouncements:
|
In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory (“ASU 2015-11”). The new standard applies only to inventory for which cost is determined by methods other than last-in, first-out and the retail inventory method, which includes inventory that is measured using first-in, first-out or average cost. Inventory within the scope of ASU 2015-11 is required to be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We adopted ASU 2015-11 during the first quarter of 2017, which did not have a material impact on our results of operations, cash flows or financial position.
| c. |
The significant accounting policies applied in the Company’s audited 2016 consolidated financial statements and notes thereto included in the Company’s Transition Report on Form 10-KT for transition period from July 1, 2016 to December 31, 2016 (the “2016 Form 10-KT”) are applied consistently in these financial statements.
|
F - 8
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 1:- |
GENERAL (Cont.)
|
| d. |
Basis of Presentation:
|
The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with Article 10 of Regulation S-X, “Interim Financial Statements” and the rules and regulations for Form 10-Q of the Securities and Exchange Commission (the “SEC”). Pursuant to those rules and regulations, the Company has condensed or omitted certain information and footnote disclosure it normally includes in its annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).
In management’s opinion, the Company has made all adjustments (consisting only of normal, recurring adjustments, except as otherwise indicated) necessary to fairly present its condensed consolidated financial position, results of operations and cash flows. The Company’s interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. These financial statements and accompanying notes should be read in conjunction with the 2016 consolidated financial statements and notes thereto included in the Company’s Transition Report on Form 10-KT for transition period from July 1, 2016 to December 31, 2016 filed with the SEC on February 21, 2017. There have been no changes in the significant accounting policies from those that were disclosed in the audited consolidated financial statements for the transition period from July 1, 2016 to December 31, 2016 included in the 2016 Form 10-KT.
| e. |
The Company depends on two contract manufacturers and several limited or single source component suppliers. Currently, the Company has entered into an agreement with a third manufacturer and is in the process of transitioning manufacturing from one manufacturer to another. During this transition period the Company will mainly rely on one contract manufacturer. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields and costs.
|
These vendors collectively account for 66.4% and 61% of the Company’s total trade payables as of March 31, 2017 (unaudited) and December 31, 2016, respectively.
The Company has the right to offset its payables to one of its contract manufacturers against vendor non-trade receivables. As of March 31, 2017 (unaudited), a total of $2,037 of these receivables met the criteria for net recognition and were offset against the corresponding accounts payable balances for this contract manufacturer in the accompanying condensed Consolidated Balance Sheets.
F - 9
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 1:- |
GENERAL (Cont.)
|
| f. |
Derivative financial instruments:
|
To protect against the increase in value of forecasted foreign currency cash flows resulting from salary and lease payments of its Israeli facilities denominated in the Israeli currency, the New Israeli Shekels (“NIS”), during the three months ended March 31, 2017, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll and lease payments denominated in NIS for a period of one to six months with hedging contracts. Accordingly, when the dollar strengthens against the foreign currencies, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the hedging contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency cash flows is offset by gains in the fair value of the hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges.
As of March 31, 2017 (unaudited), the Company entered into forward contracts to sell U.S. dollars for NIS in the amount of $9,391. These hedging contracts do not contain any credit-risk-related contingency features. See Note 4 for information on the fair value of these hedging contracts.
The fair value of the Company’s outstanding derivative instruments is as follows:
|
Three months
ended
March 31,
|
Year
ended
December 31,
|
|||||||
|
2017
|
2016
|
|||||||
|
(unaudited)
|
||||||||
|
Derivative assets:
|
||||||||
|
Derivatives designated as cash flow hedging instruments:
|
||||||||
|
Foreign exchange forward contracts
|
579
|
19
|
||||||
|
Total
|
$
|
579
|
$
|
19
|
||||
The Company recorded the fair value of derivative assets and liabilities, net in “prepaid expenses and other accounts receivable” on the Company’s condensed consolidated balance sheets.
F - 10
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 1:- |
GENERAL (Cont.)
|
The net increase in unrealized gains (losses) recognized in “accumulated other comprehensive income (loss)” on derivatives, net of tax effect, is as follows:
|
Three months ended
|
||||||||
|
March 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
(unaudited)
|
||||||||
|
Derivatives designated as cash flow hedging instruments:
|
||||||||
|
Foreign exchange forward contracts
|
909
|
668
|
||||||
The net gains reclassified from “accumulated other comprehensive income (loss)” into income (loss), are as follows:
|
Three months ended
|
||||||||
|
March 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
(unaudited)
|
||||||||
|
Derivatives designated as cash flow hedging instruments:
|
||||||||
|
Foreign exchange forward contracts
|
395
|
33
|
||||||
The Company recorded in the financial expenses, a net loss of $81 during the three months ended March 31, 2016 (unaudited), related to derivatives not qualified as hedging instruments.
No such expenses were recorded in the three months ended March 31, 2017 (unaudited).
F - 11
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 1:- |
GENERAL (Cont.)
|
| g. |
Accumulated other comprehensive income:
|
The following table summarizes the changes in accumulated balances of other comprehensive income (loss), net of taxes, for the three months ended March 31, 2017 (unaudited):
|
Unrealized gains (losses) on available-for-sale marketable securities
|
Unrealized gains (losses) on cash flow hedges
|
Unrealized gains (losses) on foreign currency translation
|
Total
|
|||||||||||||
|
Beginning balance
|
$
|
(136
|
)
|
$
|
19
|
$
|
(207
|
)
|
$
|
(324
|
)
|
|||||
|
Other comprehensive income (loss) before reclassifications
|
28
|
909
|
(243
|
)
|
694
|
|||||||||||
|
Losses (gains) reclassified from accumulated other comprehensive income (loss)
|
-
|
(395
|
)
|
-
|
(395
|
)
|
||||||||||
|
Net current period other comprehensive income (loss)
|
28
|
514
|
(243
|
)
|
299
|
|||||||||||
|
Ending balance
|
$
|
(108
|
)
|
$
|
533
|
$
|
(450
|
)
|
$
|
(25
|
)
|
|||||
The following table summarizes the changes in accumulated balances of other comprehensive loss, net of taxes, for the three months ended March 31, 2016 (unaudited):
|
Unrealized gains (losses) on available-for-sale marketable securities
|
Unrealized gains (losses) on cash flow hedges
|
Unrealized gains (losses) on foreign currency translation
|
Total
|
|||||||||||||
|
Beginning balance
|
$
|
(81
|
)
|
$
|
75
|
$
|
(287
|
)
|
$
|
(293
|
)
|
|||||
|
Other comprehensive income (loss) before reclassifications
|
87
|
668
|
(13
|
)
|
742
|
|||||||||||
|
Losses (gains) reclassified from accumulated other comprehensive income (loss)
|
1
|
(33
|
)
|
-
|
(32
|
)
|
||||||||||
|
Net current period other comprehensive income (loss)
|
88
|
635
|
(13
|
)
|
710
|
|||||||||||
|
Ending balance
|
$
|
7
|
$
|
710
|
$
|
(300
|
)
|
$
|
417
|
|||||||
F - 12
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 1:- |
GENERAL (Cont.)
|
The following table provides details about reclassifications out of accumulated other comprehensive income (loss):
|
Details about Accumulated
Other Comprehensive
Income (Loss) Components |
Amount
Reclassified from
Accumulated Other Comprehensive Income (Loss)
|
Affected Line Item in the
Statements of Operations
|
|||
|
Three months ended
|
|||||
|
March 31, 2017
|
|||||
|
Unrealized gains on cash flow hedges, net
|
58
|
Cost of revenues
|
|||
|
207
|
Research and development
|
||||
|
59
|
Sales and marketing
|
||||
|
71
|
General and administrative
|
||||
|
395
|
Total, before income taxes
|
||||
|
-
|
Income tax expense (benefit)
|
||||
|
395
|
Total, net of income taxes
|
||||
For the three months period, ended March 31, 2016 (unaudited), $33 was reclassified from accumulated other comprehensive income.
| NOTE 2:- |
INVENTORIES
|
|
March 31,
2017
|
December 31,
2016
|
|||||||
|
(unaudited)
|
||||||||
|
Raw materials
|
$
|
13,632
|
$
|
10,053
|
||||
|
Finished goods
|
47,281
|
57,310
|
||||||
|
$
|
60,913
|
$
|
67,363
|
|||||
F - 13
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 3:- |
WARRANTY OBLIGATIONS
|
Changes in the Company’s product warranty liability for the three months ended March 31, 2017 and 2016 were as follows:
|
Three months ended
March 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
(unaudited)
|
||||||||
|
Balance, at beginning of period
|
$
|
58,375
|
$
|
40,894
|
||||
|
Additions and adjustments to cost of revenues
|
5,498
|
8,002
|
||||||
|
Usage and current warranty expenses
|
(2,748
|
)
|
(2,237
|
)
|
||||
|
Balance, at end of period
|
61,125
|
46,659
|
||||||
|
Less current portion
|
(12,895
|
)
|
(13,510
|
)
|
||||
|
Long term portion
|
$
|
48,230
|
$
|
33,149
|
||||
| NOTE 4:- |
FAIR VALUE MEASUREMENTS
|
The Company applies ASC 820 (“Fair Value Measurements and Disclosures”), with respect to fair value measurements of all financial assets and liabilities.
Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.
A three-tiered fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:
| Level 1- |
Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
|
| Level 2- |
Include other inputs that are directly or indirectly observable in the marketplace.
|
| Level 3- |
Unobservable inputs which are supported by little or no market activity.
|
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
F - 14
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 4:- |
FAIR VALUE MEASUREMENTS (Cont.)
|
The following table sets forth the Company’s assets that were measured at fair value as of March 31, 2017 (unaudited) by level within the fair value hierarchy:
|
|
Balance as of
|
Fair value measurements
|
||||||||||||||
|
Description
|
March 31,
2017
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
|
Cash equivalents:
|
||||||||||||||||
|
Money market mutual funds
|
$
|
8,747
|
$
|
8,747
|
-
|
-
|
||||||||||
|
Derivative instruments asset
|
$
|
579
|
-
|
$
|
579
|
-
|
||||||||||
|
Short-term marketable securities:
|
||||||||||||||||
|
Corporate bonds
|
$
|
76,042
|
-
|
$
|
76,042
|
-
|
||||||||||
|
Governmental bonds
|
$
|
5,758
|
-
|
$
|
5,758
|
-
|
||||||||||
|
Long-term marketable securities:
|
||||||||||||||||
|
Corporate bonds
|
$
|
40,901
|
-
|
$
|
40,901
|
-
|
||||||||||
|
Governmental bonds
|
$
|
3,992
|
-
|
$
|
3,992
|
-
|
||||||||||
The following table sets forth the Company’s assets that were measured at fair value as of December 31, 2016 by level within the fair value hierarchy:
|
|
Balance as of
|
Fair value measurements
|
||||||||||||||
|
Description
|
December 31,
2016
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
|
Cash equivalents:
|
||||||||||||||||
|
Money market mutual funds
|
$
|
6,510
|
$
|
6,510
|
-
|
-
|
||||||||||
|
Derivative instruments asset
|
$
|
19
|
-
|
$
|
19
|
-
|
||||||||||
|
Short-term marketable securities:
|
||||||||||||||||
|
Corporate bonds
|
$
|
71,719
|
-
|
$
|
71,719
|
-
|
||||||||||
|
Governmental bonds
|
$
|
2,746
|
-
|
$
|
2,746
|
-
|
||||||||||
|
Long-term marketable securities:
|
||||||||||||||||
|
Corporate bonds
|
$
|
39,279
|
-
|
$
|
39,279
|
-
|
||||||||||
|
Governmental bonds
|
$
|
4,983
|
-
|
$
|
4,983
|
-
|
||||||||||
F - 15
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 4:- |
FAIR VALUE MEASUREMENTS (Cont.)
|
In addition to the assets described above, the Company’s financial instruments also include cash and cash equivalents, restricted and short-term deposits, trade receivables, other accounts receivable, trade payables, accrued expenses and other payables. The fair value of these financial instruments was not materially different from their carrying values on March 31, 2017 due to the short-term maturity of these instruments.
| NOTE 5:- |
COMMITMENTS AND CONTINGENT LIABILITIES
|
| a. |
Guarantees:
|
As of March 31, 2017 (unaudited), contingent liabilities exist regarding guarantees in the amount of $831, $55 and $176 in respect of office rent lease agreements, customs transactions and credit card limits, respectively.
| b. |
Royalty and Governmental commitments:
|
As of March 31, 2017 (unaudited), the aggregate contingent liability to the Binational Industrial Research and Development Foundation (BIRD‑F) amounted to approximately $1,158 which amount would be payable by the Company if it ever did generate revenues from such project.
The Company’s Israeli subsidiary receives research and development grants from the Office of the Chief Scientist (the OCS). In consideration for the research and development grants received from the OCS, the Company has undertaken to pay royalties as a percentage of revenues from products developed from research and development projects financed. If the Company will not generate sales of products developed with funds provided by the OCS, the Company is not obligated to pay royalties or repay the grants.
Royalties are payable at the rate of 4% to 4.5% from the time of commencement of sales of all of these products until the cumulative amount of the royalties paid equals 100% of the dollar-linked amounts of the grants received, plus interest at LIBOR rate.
As of March 31, 2017 (unaudited), the aggregate contingent liability to the OCS amounted to $477.
| c. |
Contractual purchase obligations:
|
The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories held by contract manufacturers and purchase orders initiated by the contract manufacturers and suppliers, which cannot be canceled without penalty. The Company utilizes third parties to manufacture its products. In addition, it acquires raw materials or other goods and services, including product components, by issuing to suppliers authorizations to purchase based on its projected demand and manufacturing needs.
F - 16
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 5:- |
COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)
|
As of March 31, 2017 (unaudited), the Company had non-cancelable purchase obligations totaling approximately $77,542 out of which the Company already recorded a provision for loss in the amount of $1,207.
| d. |
Legal claims:
|
From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular matter.
| NOTE 6:- |
STOCK CAPITAL
|
| a. |
Common Stock:
|
|
Authorized
|
Issued and outstanding
|
||||||||
|
Number of shares
|
|||||||||
|
March 31,
2017
|
December 31,
2016
|
March 31,
2017
|
December 31,
2016
|
||||||
|
(unaudited)
|
(unaudited)
|
||||||||
|
Stock of $0.0001 par value:
|
|||||||||
|
Common stock
|
125,000,000
|
125,000,000
|
41,532,545
|
41,259,391
|
|||||
| b. |
Stock Incentive plans:
|
The Company’s 2007 Global Incentive Plan (the “2007 Plan”) was adopted by the board of directors on August 30, 2007. On March 31, 2015, once the Company completed its Initial Public Offering (“IPO”), the 2007 Plan has been terminated and no further awards will be granted thereunder. All outstanding awards will continue to be governed by their existing terms and 379,358 available options for future grant were transferred to the Company’s 2015 Global Incentive Plan (the “2015 Plan”) and are reserved for future issuances under the 2015 plan.
The 2015 Plan became effective upon the consummation of the IPO. The 2015 Plan provides for the grant of options, RSUs and other share-based awards to directors, employees, officers and consultants of the Company and its Subsidiaries. As of March 31, 2017 (unaudited), a total of 5,890,087 (unaudited) shares of common stock were reserved for issuance under the 2015 Plan (the “Share Reserve”).
F - 17
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 6:- |
STOCK CAPITAL (Cont.)
|
|
The Share Reserve will automatically increase on January 1st of each year during the term of the 2015 Plan commencing on January 1st of the year following the year in which the 2015 Plan becomes effective in an amount equal to five percent (5%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year; provided, however, that our board of directors may provide that there will not be a January 1st increase in the Share Reserve in a given year or that the increase will be less than five percent (5%) of the shares of capital stock outstanding on the preceding December 31st.
The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is ten million (10,000,000).
|
As of March 31, 2017 (unaudited), an aggregate of 2,686,604 shares of common stock are still available for future grant under the 2015 Plan.
| c. |
Options granted to employees and members of the board of directors:
|
A summary of the activity in the share options granted to employees and members of the board of directors for the three months ended March 31, 2017 (unaudited) and related information follows:
|
Weighted
|
||||||||||||||||
|
average
|
||||||||||||||||
|
Number
|
Weighted
|
remaining
|
||||||||||||||
|
of
|
average
|
contractual
|
Aggregate
|
|||||||||||||
|
Options /
|
exercise
|
term
|
intrinsic
|
|||||||||||||
|
RSUs
|
price
|
in years
|
Value
|
|||||||||||||
|
Outstanding as of December 31, 2016
|
4,864,469
|
5.05
|
6.24
|
39,585
|
||||||||||||
|
Granted
|
445,680
|
14.64
|
||||||||||||||
|
Exercised
|
(118,698
|
)
|
2.91
|
|||||||||||||
|
Forfeited or expired
|
(5,364
|
)
|
4.50
|
|||||||||||||
|
Outstanding as of March 31, 2017
|
5,186,087
|
5.93
|
6.35
|
52,626
|
||||||||||||
|
Vested and expected to vest as of March 31, 2017
|
5,056,663
|
5.83
|
6.31
|
51,749
|
||||||||||||
|
Exercisable as of March 31, 2017
|
3,450,219
|
3.73
|
5.31
|
41,823
|
||||||||||||
The aggregate intrinsic value represents the total intrinsic value (the difference between the fair value of the Company’s common stock as of the last day of each period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last day of each period. The total intrinsic value of options exercised during the three months ended on March 31, 2017 (unaudited) was $1,419.
F - 18
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 6:- |
STOCK CAPITAL (Cont.)
|
The weighted average grant date fair values of options granted to employees and executive directors during the three months ended March 31, 2017 (unaudited) was $7.94.
| d. |
A summary of the activity in the RSUs granted to employees and members of the board of directors for the three months ended March 31, 2017 (unaudited) is as follows:
|
|
No. of
RSUs
|
Weighted average
grant date fair value
|
|||||||
|
Unvested as of December 31, 2016
|
1,515,018
|
19.74
|
||||||
|
Granted
|
471,973
|
14.61
|
||||||
|
Vested
|
(144,372
|
)
|
21.74
|
|||||
|
Forfeited
|
(39,219
|
)
|
18.21
|
|||||
|
Unvested as of March 31, 2017
|
1,803,400
|
18.34
|
||||||
e. Options and RSUs issued to non-employee consultants:
The Company has granted options and RSUs to purchase common shares to non-employee consultants as of March 31, 2017 (unaudited) as follows:
|
Outstanding
|
Exercisable
|
||||||||||||
|
as of
|
as of
|
||||||||||||
|
Issuance
|
March 31,
|
Exercise
|
March 31,
|
Exercisable
|
|||||||||
|
Date
|
2017
|
price
|
2017
|
Through
|
|||||||||
|
July 31, 2008
|
33,333
|
0.87
|
33,333
|
July 31, 2018
|
|||||||||
|
October 24, 2012
|
3,000
|
2.46
|
3,000
|
October 24, 2022
|
|||||||||
|
January 23, 2013
|
3,333
|
3.03
|
3,333
|
January 23, 2023
|
|||||||||
|
January 27, 2014
|
2,748
|
3.51
|
1,443
|
January 27, 2024
|
|||||||||
|
May 1, 2014
|
3,250
|
3.51
|
1,917
|
May 1, 2024
|
|||||||||
|
September 17, 2014
|
9,615
|
3.96
|
6,284
|
September 17, 2024
|
|||||||||
|
October 29, 2014
|
3,668
|
5.01
|
222
|
October 29, 2024
|
|||||||||
|
August 19, 2015
|
15,940
|
0.00
|
-
|
||||||||||
|
November 8, 2015
|
2,230
|
0.00
|
-
|
||||||||||
|
April 18, 2016
|
1,875
|
0.00
|
-
|
||||||||||
|
July 11, 2016
|
2,001
|
0.00
|
-
|
||||||||||
|
September 21, 2016
|
4,000
|
15.34
|
500
|
September 21, 2026
|
|||||||||
|
September 21, 2016
|
6,125
|
0.00
|
-
|
||||||||||
|
March 15, 2017
|
8,000
|
0.00
|
-
|
||||||||||
|
March 15, 2017
|
8,000
|
13.70
|
-
|
March 15, 2027
|
|||||||||
|
March 27, 2017
|
4,000
|
0.00
|
-
|
||||||||||
|
111,118
|
50,032
|
||||||||||||
The Company had accounted for its options and RSUs granted to non-employee consultants under the fair value method of ASC 505-50.
F - 19
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 6:- |
STOCK CAPITAL (Cont.)
|
In connection with the grant of stock options and RSUs to non‑employee consultants, the Company recorded stock compensation expenses in the three months ended March 31, 2017 (unaudited) and 2016 (unaudited) in the amounts $127 and $91, respectively.
| f. |
Employee Stock Purchase Plan (“ESPP”):
The Company adopted an Employee Stock Purchase Plan (the “ESPP”) effective upon the consummation of the IPO. As of March 31, 2017 (unaudited), a total of 1,301,154 shares were reserved for issuance under this plan. The number of shares of common stock reserved for issuance under the ESPP will increase automatically on January 1st of each year, for ten years, by the lesser of 1% of the total number of shares of the Company’s common stock outstanding on December 31st of the preceding calendar year or 487,643 shares. However, the Company’s board of directors may reduce the amount of the increase in any particular year at their discretion, including a reduction to zero.
The ESPP is implemented through an offering every six months. According to the ESPP, eligible employees may use up to 10% of their salaries to purchase common stock shares up to an aggregate limit of $10 per participant for every six months plan. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date
As of March 31, 2017 (unaudited), 83,319 common stock shares had been purchased under the ESPP.
As of March 31, 2017 (unaudited), 1,217,835 common stock shares were available for future issuance under the ESPP.
In accordance with ASC No. 718, the ESPP is compensatory and as such results in recognition of compensation cost.
|
F - 20
.
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 6:- |
STOCK CAPITAL (Cont.)
|
| g. |
Stock-based compensation expense for employees and consultants:
The Company recognized stock-based compensation expenses related to stock options and RSUs granted to employees and non-employees and ESPP in the condensed consolidated statement of operations for the three months ended on March 31, 2017 (unaudited) and 2016 (unaudited), as follows:
|
|
Three months ended
March 31,
2017
|
Three months ended
March 31,
2016
|
|||||||
|
Cost of revenues
|
$
|
493
|
$
|
246
|
||||
|
Research and development
|
1,205
|
724
|
||||||
|
Selling and marketing
|
1,030
|
842
|
||||||
|
General and administrative
|
884
|
819
|
||||||
|
Total stock-based compensation expense
|
$
|
3,612
|
$
|
2,631
|
||||
As of March 31, 2017 (unaudited), there was a total unrecognized compensation expense of $42,557 related to non‑vested equity‑based compensation arrangements granted under the Company’s Plans. These expenses are expected to be recognized during the period from Oct 1, 2016 through May 31, 2021.
| NOTE 7:- |
BASIC AND DILUTED NET EARNINGS PER SHARE
|
Basic net earnings per share is computed by dividing the net earnings by the weighted-average number of shares of common stock outstanding during the period.
The total weighted average number of shares related to the outstanding stock options, excluded from the calculation of diluted net earnings per share due to their anti-dilutive effect was 590,115 and 0 for the three months ended March 31, 2017 (unaudited) and 2016 (unaudited), respectively.
F - 21
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
| NOTE 7:- |
BASIC AND DILUTED NET EARNINGS PER SHARE (Cont.)
|
The following table presents the computation of basic and diluted net earnings per share for the periods presented (in thousands, except per share data):
|
Three months ended
March 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
(unaudited)
|
||||||||
|
Numerator:
|
||||||||
|
Net income
|
14,175
|
20,799
|
||||||
|
Denominator:
|
||||||||
|
Shares used in computing net earnings per share of common stock, basic
|
41,348,225
|
40,362,093
|
||||||
|
Effect of stock-based awards
|
2,489,280
|
4,215,808
|
||||||
|
Shares used in computing net earnings per share of common stock, diluted
|
43,837,505
|
44,577,901
|
||||||
|
Basic net income per share
|
$
|
0.34
|
$
|
0.52
|
||||
|
Diluted net income per share
|
$
|
0.32
|
$
|
0.47
|
||||
NOTE 8:- INCOME TAXES
| a. |
Taxes on income (tax benefit) are comprised as follows:
|
|
Three months ended
March 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
Unaudited
|
||||||||
|
Current year taxes
|
$
|
1,069
|
$
|
1,069
|
||||
|
Deferred tax income and others
|
(1,830
|
)
|
(100
|
)
|
||||
|
Taxes on income (tax benefit)
|
$
|
(761
|
)
|
$
|
969
|
|||
| b. |
Deferred income taxes:
|
Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.
F - 22
SOLAREDGE TECHNOLOGIES, INC.
AND ITS SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
U.S. dollars in thousands (except share and per share data)
NOTE 8:- INCOME TAXES (Cont.)
Significant components of the Company’s deferred tax liabilities and assets are as follows:
|
March 31,
|
December 31,
|
|||||||
|
2017
|
2016
|
|||||||
|
(Unaudited)
|
||||||||
|
Assets in respect of:
|
||||||||
|
Research and Development carryforward expenses- temporary differences
|
$
|
1,792
|
$
|
908
|
||||
|
Stock based compensation
|
1,279
|
1,039
|
||||||
|
Other reserves
|
1,013
|
868
|
||||||
|
Net deferred tax assets
|
$
|
4,084
|
$
|
2,815
|
||||
During fiscal year 2016, the Company determined that the positive evidence outweighs the negative evidence for deferred tax assets and concluded that these deferred tax assets are realizable on a "more likely than not" basis. This determination was mainly due to expected future results of positive operations and earnings history.
| c. |
Uncertain tax positions:
|
The Company recognized a total liability for uncertain tax positions in the amount of $264 as of March 31, 2017.
| NOTE 9:- |
CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS
|
| a. |
For the three month period ended March 31, 2017 (unaudited) and 2016 (unaudited), the Company had one and two major customers that accounted for 12.74% and 26.71% of its condensed consolidated revenues, respectively.
|
| b. |
As of March 31, 2017 (unaudited), one customer accounted for approximately 16.57% of the Company’s net accounts receivable and as of December 31, 2016, three major customers accounted for approximately 20.15% of the Company’s net accounts receivable.
|
F - 23
Forward-Looking Statements
Statements contained in this Form 10-Q or statements incorporated by reference from documents we have filed with the Securities and Exchange Commission may contain forward-looking statements that are based on our management's expectations, estimates, projections, beliefs and assumptions in accordance with information currently available to our management. Forward-looking statements should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in Part 1, Item 1 of this report. This discussion contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, technology developments, new products and services, financing and investment plans, dividend policy, competitive position, industry and regulatory environment, potential growth opportunities and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as "anticipate," "believe," "could," "seek," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "will," "would" or similar expressions and the negatives of those terms.
Forward looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward looking statements. Given these uncertainties, you should not place undue reliance on forward looking statements. Also, forward looking statements represent our management's beliefs and assumptions only as of the date of this filing. Important factors that could cause actual results to differ materially from our expectations include:
| · |
our limited history of profitability, which may not continue in the future;
|
| · |
our limited operating history, which makes it difficult to predict future results;
|
| · |
future demand for solar energy solutions;
|
| · |
changes to net metering policies or the reduction, elimination or expiration of government subsidies and economic incentives for on‑grid solar electricity applications;
|
| · |
the results of the 2016 U.S. presidential and congressional elections may create regulatory uncertainty for the clean energy sector and the solar energy sector in particular and may materially harm our business, financial condition and results of operations;
|
| · |
federal, state and local regulations governing the electric utility industry with respect to solar energy;
|
| · |
the retail price of electricity derived from the utility grid or alternative energy sources;
|
| · |
interest rates and supply of capital in the global financial markets in general and in the solar market specifically;
|
| · |
competition, including introductions of power optimizer, inverter and solar PV system monitoring products by our competitors;
|
| · |
developments in alternative technologies or improvements in distributed solar energy generation;
|
| · |
historic cyclicality of the solar industry and periodic downturns;
|
| · |
defects or performance problems in our products;
|
4
| · |
our ability to forecast demand for our products accurately and to match production with demand;
|
| · |
our dependence on ocean transportation to deliver our products in a cost effective manner;
|
| · |
we depend on two contract manufacturers and several limited or single source component suppliers; we have recently entered into an agreement with an additioinal contract manufacturer and are in the process of ramping up manufacturing with the new manufacturer. During this ramp up period we will mainly rely on one contract manufacturer;
|
| · |
capacity constraints, delivery schedules, manufacturing yields and costs of our contract manufacturers and availability of components;
|
| · |
delays, disruptions and quality control problems in manufacturing;
|
| · |
shortages, delays, price changes or cessation of operations or production affecting our suppliers of key components;
|
| · |
business practices and regulatory compliance of our raw material suppliers;
|
| · |
performance of distributors and large installers in selling our products;
|
| · |
our customer's financial stability, creditworthiness and debt leverage ratio;
|
| · |
our ability to retain key personnel and attract additional qualified personnel;
|
| · |
our ability to effectively design, launch, market and sell new generations of our products and services;
|
| · |
our ability to maintain our brand and to protect and defend our intellectual property;
|
| · |
our ability to retain, and events affecting, our major customers;
|
| · |
our ability to manage effectively the growth of our organization and expansion into new markets;
|
| · |
fluctuations in currency exchange rates;
|
| · |
unrest, terrorism or armed conflict in Israel;
|
| · |
general economic conditions in our domestic and international markets; and
|
| · |
consolidation in the solar industry among our customers and distributors; and
|
| · |
the other factors set forth under "Item 1A. Risk Factors" in "Part II-OTHER INFORMATION" section of this report.
|
Except as required by law, we assume no obligation to update these forward‑looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward‑looking statements, even if new information becomes available in the future.
Overview
We have invented an intelligent inverter solution that has changed the way power is harvested and managed in a solar photovoltaic ("PV") system. Our direct current ("DC") optimized inverter system is designed to maximize power generation at the individual PV module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. Our systems allow for superior power harvesting and module management by deploying power optimizers at each PV module while maintaining a competitive system cost by using a simplified DC AC inverter. Our systems are monitored through our cloud-based monitoring platform that enables lower system operating and maintenance ("O&M") costs. We believe that these benefits, along with our comprehensive and advanced safety features, are highly valued by our customers.
5
Our revenues for the three months ended March 31, 2017 and 2016 were $115.1 million and $125.2 million, respectively. Gross margin was 33.6% and 32.5% for the three months ended March 31, 2017 and 2016, respectively. Net income was $14.2 million and $20.8 million for the three months ended March 31, 2017 and 2016, respectively.
As of March 31, 2017, we have shipped approximately 16.8 million power optimizers and 691,000 inverters. Approximately 427,000 installations, many of which may include multiple inverters, are currently connected to, and monitored through, our cloud‑based monitoring platform. As of March 31, 2017, we have shipped approximately 4.7 GW of our DC optimized inverter systems. Our products are sold in approximately 53 countries, and are installed in solar PV systems in 100 countries.
As of March 31, 2017, approximately 241,000 indirect customers had registered with us through our cloud‑based monitoring platform.
Key Operating Metrics
In managing our business and assessing financial performance, we supplement the information provided by the financial statements with other operating metrics. These operating metrics are utilized by our management to evaluate our business, measure our performance, identify trends affecting our business and formulate projections. We use metrics relating to shipments (inverters shipped, power optimizers shipped and megawatts shipped) to evaluate our sales performance and to track market acceptance of our products. We use metrics relating to monitoring (systems monitored) to evaluate market acceptance of our products and usage of our solution.
We provide the "megawatts shipped" metric, which is calculated based on nameplate capacity shipped, to show adoption of our system on a nameplate capacity basis. Nameplate capacity shipped is the maximum rated power output capacity of an inverter and corresponds to our financial results in that higher total capacities shipped are generally associated with higher total revenues. However, revenues increase with each additional unit, not necessarily each additional MW of capacity, sold. Accordingly, we also provide the "inverters shipped" and "power optimizers shipped" operating metrics.
|
Three Months Ended
March 31, |
||||||||
|
2017
|
2016
|
|||||||
|
Inverters shipped
|
57,761
|
52,333
|
||||||
|
Power optimizers shipped
|
1,469,677
|
1,417,469
|
||||||
|
Megawatts shipped (1)
|
455
|
416
|
||||||
——————
| (1) |
Calculated based on the aggregate nameplate capacity of inverters shipped during the applicable period. Nameplate capacity is the maximum rated power output capacity of an inverter as specified by the manufacturer.
|
Results of Operations
The results of operations presented below should be reviewed in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this report.
6
The following table sets forth selected consolidated statements of operations data for each of the periods indicated.
|
Three Months Ended
March 31,
|
||||||||
|
2017
|
2016
|
|||||||
|
(In thousands)
|
||||||||
|
Revenues
|
$
|
115,054
|
$
|
125,205
|
||||
|
Cost of revenues
|
76,378
|
84,471
|
||||||
|
Gross profit
|
38,676
|
40,734
|
||||||
|
Operating expenses:
|
||||||||
|
Research and development, net
|
11,458
|
8,709
|
||||||
|
Sales and marketing
|
10,775
|
8,826
|
||||||
|
General and administrative
|
4,439
|
3,460
|
||||||
|
Total operating expenses
|
26,672
|
20,995
|
||||||
|
Operating income
|
12,004
|
19,739
|
||||||
|
Financial income, net
|
1,410
|
2,029
|
||||||
|
Income before taxes on income
|
13,414
|
21,768
|
||||||
|
Taxes on income (tax benefit)
|
(761
|
)
|
969
|
|||||
|
Net income
|
$
|
14,175
|
$
|
20,799
|
||||
Comparison of the Three Months Ended March 31, 2017 and 2016
Revenues
|
Three Months Ended
March 31,
|
Three Months Ended
March,
2016 to 2017
|
|||||||||||||||
|
2017
|
2016
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Revenues
|
$
|
115,054
|
$
|
125,205
|
$
|
(10,151
|
)
|
(8.1
|
)%
|
|||||||
Revenues decreased by $10.2 million, or 8.1%, for the three months ended March 31, 2017 as compared to the three months ended March 31, 2016, primarily due to reduced revenues in the U.S. market prompted by an average selling price erosion and a general slowdown in US residential installations in the quarter ended March 31, 2017. The number of power optimizers sold remained stable in the three months ended March 31, 2017 compared to the three months ended March 31, 2016. The number of inverters sold increased by approximately 3,200 units, or 5.9%, from approximately 54,500 units in the three months ended March 31, 2016 to approximately 57,700 units in the three months ended March 31, 2017. Our blended average selling price per watt for units shipped decreased by $0.043, or 14.2%, in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016, primarily due to (i) an increase in sales of commercial products that are characterized by lower average selling prices per watt; (ii) price erosion in the overall inverter market; (iii) a change in our customer mix, which included a higher portion of sales to large customers to whom we provide volume discounts.
Cost of Revenues and Gross Profit
|
Three Months Ended
March 31,
|
Three Months Ended
March 31,
2016 to 2017
|
|||||||||||||||
|
2017
|
2016
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Cost of revenues
|
$
|
76,378
|
$
|
84,471
|
$
|
(8,093
|
)
|
(9.6
|
)%
|
|||||||
|
Gross profit
|
$
|
38,676
|
$
|
40,734
|
$
|
(2,058
|
)
|
(5.1
|
)%
|
|||||||
Cost of revenues decreased by $8.1 million, or 9.6%, in the three months ended March 31, 2017, as compared to the three months ended March 31, 2016, primarily due to (i) reductions in per unit production costs; (ii) reductions derived from increased efficiency in our supply chain; and (iii) decreased warranty expenses derived from increased efficiency in our products quality and reduction in per unit cost of replaced faulty products. These decreases were partially offset by increase in personnel-related costs resulting from an increase in our operations and support headcount and increase of depreciation of machines and automated assembly lines. Gross profit as a percentage of revenue increased from 32.5% in the three months ended March 31, 2016 to 33.6% in the three months ended March 31, 2017, primarily due to reductions in per unit production costs, increased efficiency in our supply chain and general economies of scale in our personnel-related costs and other costs associated with our support and operations departments.
7
Operating Expenses:
Research and Development, Net
|
Three Months Ended
March 31,
|
Three Months Ended
March 31,
2016 to 2017
|
|||||||||||||||
|
2017
|
2016
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Research and development, net
|
$
|
11,458
|
$
|
8,709
|
$
|
2,749
|
31.6
|
%
|
||||||||
Research and development, net increased by $2.7 million, or 31.6%, in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016, primarily due to an increase in personnel-related costs of $1.9 million resulting from an increase in our research and development headcount. The increase in headcount reflects our continued investment in enhancing our existing products as well as activities associated with bringing new products to market. In addition, the use of external consultants, deprecation expenses and materials consumption increased by $0.5 million, $0.2 million and $0.1 million, respectively, in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016.
Sales and Marketing
|
Three Months Ended
March 31,
|
Three Months Ended
March 31,
2016 to 2017
|
|||||||||||||||
|
2017
|
2016
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Sales and marketing
|
$
|
10,775
|
$
|
8,826
|
$
|
1,949
|
22.1
|
%
|
||||||||
Sales and marketing expenses increased by $1.9 million, or 22.1%, in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016, primarily due to an increase in personnel-related costs of $1.4 million related to an increase in headcount associated with supporting our sales in the U.S. and Europe. In addition, expenses related to trade shows and marketing activities, expenses related to external consultants and sub-contractors and expenses associated with our worldwide sales offices, travel and other overhead costs increased by $0.2 million, $0.2 million and $0.1 million, respectively, in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016.
General and Administrative
|
Three Months
Ended
March 31,
|
Three Months
Ended
March 31,
2016 to 2017
|
|||||||||||||||
|
2017
|
2016
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
General and administrative
|
$
|
4,439
|
$
|
3,460
|
$
|
979
|
28.3
|
%
|
||||||||
General and administrative expenses increased by $1.0 million, or 28.3%, in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016, primarily due to an increase in doubtful debts in the amount of $1.0 million mostly driven by one of our customers that declared bankruptcy, and $0.2 million in expenses related to accounting, tax, legal and information systems consulting in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016. These increases were offset by decrease of $0.2 million in personnel-related costs due to decrease in management bonus payments.
8
Financial income (expenses), net
|
Three Months Ended
March 31,
|
Three Months Ended
March 31,
2016 to 2017
|
|||||||||||||||
|
2017
|
2016
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Financial income , net
|
$
|
1,410
|
$
|
2,029
|
$
|
(619
|
)
|
(30.5
|
)%
|
|||||||
Financial income decreased by $0.6 million in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016, primarily due to a decrease of $1.0 million in foreign exchange fluctuations between the Euro and the New Israeli Shekel against the U.S. Dollar in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016. This was offset by an increase of $0.3 million of interest income, net of accretion (amortization) of discount (premium) on marketable securities and a decrease of $0.1 million in expenses related to hedging transactions in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016.
Taxes on Income
|
Three Months Ended
March 31,
|
Three Months Ended
March 31,
2016 to 2017
|
|||||||||||||||
|
2017
|
2016
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Taxes on income (tax benefit)
|
$
|
(761
|
)
|
$
|
969
|
$
|
(1,730
|
)
|
N/A
|
|||||||
Tax benefits were $0.8 million in the three months ended March 31, 2017 compared to taxes on income of $1.0 million in the three months ended March 31, 2016, primarily due to an increase of $1.2 million in deferred tax asset in the three months ended March 31, 2017 and a $0.5 million income related to previous years tax credit.
Net Income
|
Three Months Ended
March 31,
|
Three Months Ended
March 31,
2016 to 2017
|
|||||||||||||||
|
2017
|
2016
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Net income
|
$
|
14,175
|
$
|
20,799
|
$
|
(6,624
|
)
|
(31.9
|
)%
|
|||||||
As a result of the factors discussed above, net income decreased by $6.6 million, or 31.9%, in the three months ended March 31, 2017 as compared to the three months ended March 31, 2016.
Liquidity and Capital Resources
The following table shows our cash flow from operating activities, investing activities and financing activities for the stated periods:
|
Three Months Ended
March 31, |
||||||||
|
2017
|
2016
|
|||||||
|
(in thousands)
|
||||||||
|
Net cash provided by operating activities
|
$
|
25,666
|
$
|
15,342
|
||||
|
Net cash used in investing activities
|
(10,437
|
)
|
(38,473
|
)
|
||||
|
Net cash provided by financing activities
|
371
|
1,167
|
||||||
|
Increase (decrease) in cash and cash equivalents
|
$
|
15,600
|
$
|
(21,964
|
)
|
|||
9
As of March 31, 2017, our cash and cash equivalents were $119.9 million. This amount does not include $126.7 million invested in available-for-sale marketable securities and $1.0 million of restricted cash (primarily held to secure bank guarantees securing office lease payments). We believe that cash provided by operating activities as well as our cash and cash equivalents will be sufficient to meet our anticipated cash needs for at least the next 12 months.
Operating Activities
For the three months ended March 31, 2017, cash provided by operating activities was $25.7 million, derived mainly from a net income of $14.2 million that included $4.2 million of non-cash expenses, an increase of $10.0 million in trade payables and other accounts payable, $2.7 million in warranty obligations, $2.1 million of deferred revenues and a decrease of $6.5 million in inventories, which were offset by an increase of $8.1 million in trade receivables, net, $4.6 million in prepaid expenses and other receivables and a decrease of $1.3 million in accruals for employees.
For the three months ended March 31, 2016, cash used in operating activities was $15.3 million derived mainly from a net income of $20.8 million that included $3.7 million of non-cash expenses, an increase of $5.8 million in warranty obligations, $2.5 million in deferred revenues, a decrease of $6.7 million in prepaid expenses and other receivables and $2.0 million in inventories which was offset by an increase of $9.4 million in trade receivables, and a decrease of $16.2 million in trade payables and other accounts payable and $0.6 million accruals for employees.
Investing Activities
During the three months ended March 31, 2017, net cash used in investing activities was $10.4 million, of which $24.1 million was invested in available-for-sale marketable securities, $1.9 million related to capital investments in laboratory equipment, end of line testing equipment, automated assembly lines, manufacturing tools and leasehold improvements and $0.1 million increase in restricted cash and short and long-term lease deposit. This was offset by $15.7 million from the maturities of available-for-sale marketable securities.
During the three months ended March 31, 2016, net cash used in investing activities was $38.5 million, of which $36.0 million was invested in available-for-sale marketable securities, and $5.9 million related to capital investments in laboratory equipment, end of line testing equipment, manufacturing tools and leasehold improvements. This was offset by a $2.4 million decrease in restricted cash and $1.0 million from the maturities of available-for-sale marketable securities.
Financing Activities
For the three months ended March 31, 2017, net cash provided by financing activities was $0.4 million, all attributed to cash received from the exercise of employee and non-employee stock options.
For the three months ended March 31, 2016, net cash provided by financing activities was $1.2 million, all attributed to cash received from the exercise of employee and non-employee stock options.
Debt Obligations
Revolving Line of Credit
In February 2015, we amended and restated a revolving line of credit agreement with Silicon Valley Bank, which permitted aggregate borrowings of up to $40 million. The revolving line of credit terminated on December 31, 2016.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements.
10
We are exposed to market risk in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates, customer concentrations and interest rates. We do not hold or issue financial instruments for trading purposes.
Foreign Currency Exchange Risk
Approximately 30.5% and 18.7% of our revenues for the three months ended March 31, 2017 and 2016, respectively, were earned in non‑U.S. Dollar denominated currencies, principally the Euro. Our expenses are generally denominated in the currencies in which our operations are located, primarily the U.S. Dollar and New Israeli Shekel, and to a lesser extent the Euro. Our New Israeli Shekel‑denominated expenses consist primarily of personnel and overhead costs. Our consolidated results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. A hypothetical 10% change in foreign currency exchange rates during the three months ended March 31, 2017, between the Euro and the U.S. Dollar would increase or decrease our net income by $2.6 million for the three months ended March 31, 2017. A hypothetical 10% change in foreign currency exchange rates during the three months ended March 31, 2017, between the New Israeli Shekel and the U.S. Dollar would increase or decrease our net income by $1.5 million for the three months ended March 31, 2017.
For purposes of our consolidated financial statements, local currency assets and liabilities are translated at the rate of exchange to the U.S. Dollar on the balance sheet date and local currency revenues and expenses are translated at the exchange rate as of the date of the transaction or at the average exchange rate to the U.S. Dollar during the reporting period.
To date, we have used derivative financial instruments, specifically foreign currency forward contracts, to manage exposure to foreign currency risks by hedging a portion of our account receivable balances denominated in Euros expected to be paid within nine months. Our foreign currency forward contracts are expected to mitigate exchange rate changes related to the hedged assets. We do not use derivative financial instruments for speculative or trading purposes.
We had cash and cash equivalents of $119.9 million and available-for-sale marketable securities with an estimated fair value of $126.7 million on March 31, 2017, which securities were held for working capital purposes. We do not enter into investments for trading or speculative purposes. Since most of our cash and cash equivalents are held in U.S. Dollar‑denominated money market funds, we believe that our cash and cash equivalents do not have any material exposure to changes in exchange rates.
Concentrations of Major Customers
Our trade accounts receivables potentially expose us to a concentration of credit risk with our major customers. As of March 31, 2017, one major customer accounted for approximately 16.6% of our consolidated trade receivables balance. We currently do not foresee a credit risk associated with this receivable.
Disclosure Controls and Procedures
Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of March 31, 2017. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.
11
Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective and operating to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and to provide reasonable assurance that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
Based on an evaluation by our chief executive officer and chief financial officer, such officers concluded that there have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
In the normal course of business, we may from time to time be named as a party to various legal claims, actions and complaints. It is impossible to predict with certainty whether any resulting liability from any such legal claims, actions or complaints would have a material adverse effect on our financial position, results of operations or cash flows.
There have been no material changes to the risk factors as described in Part I, Item 1A, "Risk Factors," in our Annual Report on Form 10-KT for the year ended Decemebr 31, 2016 other than the supplemental risk factor set forth below:
We rely on a limited amount of contract manufacturers and, for a period of time, will rely on one contract manufacturer for some manuacturing.
We depend on two contract manufacturers and several limited or single source component suppliers; we have recently entered into an agreement with a new contract manufacturer and are in the process of rampring up manufacturing with the new manufacturer. During this ramp up period we will mainly rely on one contract manufacturer. Any change in our relationship with our contract manufacturers or changes to contractual terms of our agreements with the contract manufacturers could adversely affect our financial condition and results of operations.
(a) Recent Sales of Unregistered Securities
None.
(b) Use of Proceeds
On March 31, 2015, we consummated the initial public offering consisting of 8,050,000 shares of our common stock at a public offering price of $18.00 per share. The offering terminated after the sale of all securities registered in the offering. Goldman, Sachs & Co. acted as joint book-running managers for the offering. Needham & Company, Canaccord Genuity Inc. and Roth Capital Partners acted as co-managers. As a result of the offering, we received total net offering proceeds of $131.2 million, after deducting total expenses of $13.7 million, consisting of underwriting discounts and commissions of $10.1 million and offering related expenses paid by us of $3.6 million. No payments for such expenses were made directly or indirectly to (i) any of our officers or directors or their associates, (ii) any persons owning 10% or more of any class of our equity securities, or (iii) any of our affiliates. The proceeds from the initial public offering have been used for general corporate purposes, including working capital and expansion of our business into additional markets.
12
None.
Not applicable.
We previously disclosed in our proxy statement for the 2016 Annual Meeting of Stockholders that we anticipated filing our proxy statement for the 2017 Annual Meeting of Stockholders within 120 days after the end of our fiscal year on June 30, 2016, and hold our 2017 Annual Meeting shortly thereafter. However, because we have recently changed our fiscal year end to December 31, we presently intend to hold our 2017 Annual Meeting of Stockholders (the "2017 Annual Meeting") at 47505 Seabridge Drive, Fremont, CA, on May 10, 2017, at 10 a.m. local time.
13
|
Exhibit
No.
|
Description
|
Incorporation by Reference
(where a report is indicated below, that
document has been previously filed with
the SEC and the applicable exhibit is
incorporated by reference thereto)
|
||
|
10.1
|
2015 Global Incentive Plan
|
Filed with this report.
|
||
|
31.1
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a).
|
Filed with this report.
|
||
|
31.2
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a).
|
Filed with this report.
|
||
|
32.1
|
Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Filed with this report
|
||
|
32.2
|
Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Filed with this report.
|
||
|
101.INS
|
XBRL Instance Document
|
Filed with this report.
|
||
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
Filed with this report.
|
||
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
Filed with this report.
|
||
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
Filed with this report.
|
||
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
Filed with this report.
|
||
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
Filed with this report.
|
14
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
Date: May 10, 2017
|
SOLAREDGE TECHNOLOGIES, INC.
/s/ Guy Sella
Guy Sella
Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
|
|
Date: May 10, 2017
|
/s/ Ronen Faier
Ronen Faier
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
15